Analysis of the Cost Effectiveness of Concurrent Cisplatin-Based Chemoradiation in Cervical Cancer: Implications from Five Randomized Trials

By Rose P.G.   Lappas P.T.  

Gynecologic Oncology, Vol. 78, Iss. 1, 2000-07 ,pp. : 3-6

Elsevier

Access to resources Recommend Favorite

Concurrent Cisplatin-Based Chemoradiation for Cervical Carcinoma: Tumor Response, Toxicity, and Serum Cytokine Profiles

By Yang Yuh-Cheng   Wang Kung-Liahng   Su Tsung-Hsien   Liao Hui-Fen   Wu Meng-Hao   Chen Tze-Chien   Huang Ming-Chao   Chen Yu-Jen  

Cancer Investigation, Vol. 24, Iss. 4, 2006-07 ,pp. : 390-395

Informa Healthcare

Access to resources Recommend Favorite

Determinants of Response to a Cisplatin-Based Regimen as Neoadjuvant Chemotherapy in Stage IB-IIB Invasive Cervical Cancer

By Bolis G.   van Zainten-Przybysz I.   Scarfone G.   Zanaboni F.   Scarabelli C.   Tateo S.   Calabrese M.   Parazzini F.  

Gynecologic Oncology, Vol. 63, Iss. 1, 1996-10 ,pp. : 62-65

Academic Press

Access to resources Recommend Favorite

Accelerated Cisplatin-based Chemotherapy for Advanced Bladder Cancer

By Boshoff C.   Oliver R.T.D.   Gallagher C.J.   J. O.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1633-1636

Elsevier

Access to resources Recommend Favorite

Cisplatin-DNA adduct formation in patients treated with cisplatin-based chemoradiation: lack of correlation between normal tissues and primary tumor

By Hoebers F.   Pluim D.   Hart A.   Verheij M.   Balm A.   Fons G.   Rasch C.   Schellens J.   Stalpers L.   Bartelink H.   Begg A.  

Cancer Chemotherapy and Pharmacology, Vol. 61, Iss. 6, 2008-05 ,pp. : 1075-1081

Springer Publishing Company

Access to resources Recommend Favorite